Key statistics
On Friday, Bicycle Therapeutics PLC (50BA:FRA) closed at 22.40, -13.85% below its 52-week high of 26.00, set on Feb 29, 2024.
52-week range
Open | 21.80 |
---|---|
High | 22.40 |
Low | 21.80 |
Bid | 22.20 |
Offer | 23.40 |
Previous close | 22.20 |
Average volume | 474.86 |
---|---|
Shares outstanding | 68.99m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 1.75bn USD |
EPS (TTM) | -3.81 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 14:29 BST.
More ▼
Press releases
- Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
- Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
- PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications
More ▼